Catherine Glover

833 total citations
23 papers, 227 citations indexed

About

Catherine Glover is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Catherine Glover has authored 23 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 7 papers in Infectious Diseases and 6 papers in Health. Recurrent topics in Catherine Glover's work include Influenza Virus Research Studies (7 papers), Vaccine Coverage and Hesitancy (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Catherine Glover is often cited by papers focused on Influenza Virus Research Studies (7 papers), Vaccine Coverage and Hesitancy (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Catherine Glover collaborates with scholars based in Australia, United States and United Kingdom. Catherine Glover's co-authors include Kristine Macartney, Alan Leeb, Alexis Pillsbury, Tom Snelling, Patrick Cashman, Helen Quinn, Nicholas Wood, Nigel W. Crawford, Christopher C. Blyth and Parveen Fathima and has published in prestigious journals such as JAMA, Vaccine and BMJ Open.

In The Last Decade

Catherine Glover

21 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Glover Australia 11 119 88 64 38 25 23 227
Alan Leeb Australia 11 212 1.8× 133 1.5× 160 2.5× 22 0.6× 17 0.7× 27 320
Johanna Chapin-Bardales United States 7 107 0.9× 274 3.1× 108 1.7× 47 1.2× 11 0.4× 17 359
Petra J. Woestenberg Netherlands 10 217 1.8× 33 0.4× 34 0.5× 77 2.0× 8 0.3× 23 269
Sara De Nitto Italy 13 224 1.9× 155 1.8× 235 3.7× 5 0.1× 24 1.0× 20 373
Meli̇ha Çağla Sönmezer Türkiye 9 81 0.7× 106 1.2× 37 0.6× 13 0.3× 42 1.7× 48 273
Dapeng Yin China 7 187 1.6× 88 1.0× 40 0.6× 12 0.3× 9 0.4× 19 296
Majid Darraj Saudi Arabia 8 46 0.4× 170 1.9× 87 1.4× 36 0.9× 18 0.7× 28 286
Rafael Perelló Spain 12 149 1.3× 83 0.9× 10 0.2× 47 1.2× 17 0.7× 25 310
Patrick Obermeier Germany 12 244 2.1× 190 2.2× 99 1.5× 9 0.2× 10 0.4× 25 440
Sameera Pathirannehelage United Kingdom 9 211 1.8× 73 0.8× 71 1.1× 14 0.4× 2 0.1× 11 314

Countries citing papers authored by Catherine Glover

Since Specialization
Citations

This map shows the geographic impact of Catherine Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Glover more than expected).

Fields of papers citing papers by Catherine Glover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Glover. The network helps show where Catherine Glover may publish in the future.

Co-authorship network of co-authors of Catherine Glover

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Glover. A scholar is included among the top collaborators of Catherine Glover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Glover. Catherine Glover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glover, Catherine, et al.. (2025). The effect of diet on Parkinson’s disease progression, symptoms and severity: a review of randomised controlled trials. Proceedings of The Nutrition Society. 1–15.
2.
Glover, Catherine, et al.. (2024). Surveillance of adverse events following immunisation in Australia, COVID-19 vaccines, 2021. Communicable Diseases Intelligence. 48. 2 indexed citations
3.
Glover, Catherine, et al.. (2024). National pharmacovigilance of seasonal influenza vaccines in Australia. The Medical Journal of Australia. 221(4). 178–181. 1 indexed citations
4.
Craft, Sam, et al.. (2023). Synthetic cannabinoid use in an adult male prison in the UK. International Journal of Drug Policy. 122. 104219–104219. 7 indexed citations
5.
Wood, Nicholas, Laura López, Catherine Glover, et al.. (2023). Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia. The Lancet Regional Health - Western Pacific. 31. 100684–100684. 2 indexed citations
6.
Deng, Lucy, Laura López, Catherine Glover, et al.. (2023). Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox. JAMA. 329(23). 2091–2091. 12 indexed citations
7.
Li‐Kim‐Moy, Jean, Anastasia Phillips, Catherine Glover, et al.. (2023). Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–2020. BMJ Open. 13(1). e067287–e067287. 10 indexed citations
8.
López, Laura, David Burgner, Catherine Glover, et al.. (2022). Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant. The Lancet Regional Health - Western Pacific. 27. 100604–100604. 27 indexed citations
9.
Williams, Phoebe, Archana Koirala, Gemma Saravanos, et al.. (2022). COVID ‐19 in New South Wales children during 2021: severity and clinical spectrum. The Medical Journal of Australia. 217(6). 303–310. 14 indexed citations
10.
Phillips, Anastasia, Catherine Glover, Alan Leeb, et al.. (2021). Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance. BMJ Open. 11(3). e043880–e043880. 10 indexed citations
11.
Quinn, Helen, Catherine Glover, Sonia Dougherty, et al.. (2021). Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditions. Communicable Diseases Intelligence. 45. 10 indexed citations
12.
Dey, Aditi, Han Wang, Helen Quinn, et al.. (2021). Surveillance of adverse events following immunisation in Australia annual report, 2019. Communicable Diseases Intelligence. 45. 9 indexed citations
13.
Phillips, Anastasia, Catherine Glover, Kendal Chidwick, et al.. (2020). Safety of live attenuated herpes zoster vaccine in adults 70–79 years: A self-controlled case series analysis using primary care data from Australia’s MedicineInsight program. Vaccine. 38(23). 3968–3979. 11 indexed citations
14.
Glover, Catherine, Nigel W. Crawford, Alan Leeb, Nicholas Wood, & Kristine Macartney. (2020). Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine. 38(31). 4892–4900. 13 indexed citations
15.
Jacoby, Peter, Catherine Glover, Parveen Fathima, et al.. (2020). Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ Open. 10(2). e031851–e031851. 7 indexed citations
16.
Dey, Aditi, Han Wang, Helen Quinn, et al.. (2020). Surveillance of adverse events following immunisation in Australia: annual report, 2018. Communicable Diseases Intelligence. 44. 18 indexed citations
17.
Bazzano, Alessandra N., Eboni G. Price‐Haywood, Elizabeth Nauman, et al.. (2019). <p>Older patients’ preferences and views related to non-face-to-face diabetes chronic care management: a qualitative study from southeast Louisiana</p>. Patient Preference and Adherence. Volume 13. 901–911. 6 indexed citations
18.
Pillsbury, Alexis, Catherine Glover, Peter Jacoby, et al.. (2018). Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia. BMJ Open. 8(10). e023263–e023263. 37 indexed citations
19.
Gowda, Charitha, et al.. (2018). Enhanced identification of maternal hepatitis C virus infection using existing public health surveillance systems. Paediatric and Perinatal Epidemiology. 32(4). 401–410. 10 indexed citations
20.
Glover, Catherine, Loretta M. Hillier, & Iris Gutmanis. (2007). Stakeholder Engagement and Public Policy Evaluation: Factors Contributing to the Development and Implementation of a Regional Network for Geriatric Care. Healthcare Management Forum. 20(4). 6–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan Leeb Breakdown of academic impact, for papers by Johanna Chapin-Bardales Breakdown of academic impact, for papers by Petra J. Woestenberg Breakdown of academic impact, for papers by Sara De Nitto Breakdown of academic impact, for papers by Meli̇ha Çağla Sönmezer Breakdown of academic impact, for papers by Dapeng Yin Breakdown of academic impact, for papers by Majid Darraj Breakdown of academic impact, for papers by Rafael Perelló Breakdown of academic impact, for papers by Patrick Obermeier Breakdown of academic impact, for papers by Sameera Pathirannehelage
Rankless by CCL
2026